FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286700957> ?p ?o ?g. }

• W4286700957 abstract "<h3>Introduction/Purpose</h3> Percutaneous sclerotherapy (PS) is an effective treatment for symptomatic ­­lymphatic malformations (LM) of the head/neck. Some LMs present in the neonatal period with fulminant or rapidly progressing symptoms. The purpose of this study was to study the indications, technique, and efficacy of PS for head/neck LM in neonate and infant patients. <h3>Methods</h3> We reviewed records of a large, single-institution vascular anomalies clinic. Patients who underwent PS for LM of the head/neck at age ≤ 12 months were studied. The clinical, anatomic, and technical aspects of each treatment, rates of procedural and laboratory complications, post-treatment clinical and imaging outcomes were analyzed. <h3>Results</h3> 22 patients underwent 36 PS treatments during the first year of life. The median age at first PS was 6.2 months (range 2–320 days). Severe airway compromise was the most frequent indication (31.8%) followed by poor feeding, pain/discomfort, motor skill delay, rapid lesion growth (9.1%, each), and retinal hemorrhage (4.5%). 72.7% of LM were DeSerres Grade ≥ 3. Sclerosants included doxycycline (80.5% of cases), sodium tetradecyl (55.5%), bleomycin (11.1%) and ethanol (2.8%). There were no procedural complications; sclerosant-related complications included transient metabolic acidosis (8.3%) and hemolytic anemia (5.5%). Median clinical follow-up duration was 3.7 years, IQR 0.6–4.8 years). 47.6% of patients showed >75% lesion size reduction and 19.0% showed minimal response (<25% lesion reduction). At last follow-up, 71.4% of children were developmentally normal and asymptomatic, 23.8% had mild/intermittent ongoing symptoms, and 4.8% required tracheostomy and long-term care assistance. <h3>Conclusion</h3> PS is a safe and effective treatment for carefully selected large or symptomatic LM of the head and neck in neonates and infants.­ <h3>Disclosures</h3> <b>M. Caton:</b> None. <b>M. Duvvuri:</b> None. <b>A. Baker:</b> None. <b>E. Smith:</b> None. <b>K. Narsinh:</b> None. <b>M. Amans:</b> None. <b>S. Hetts:</b> None. <b>R. Higashida:</b> None. <b>D. Cooke:</b> None. <b>C. Dowd:</b> None." @default.
• W4286700957 created "2022-07-23" @default.
• W4286700957 creator A5001897335 @default.
• W4286700957 creator A5006613712 @default.
• W4286700957 creator A5029305030 @default.
• W4286700957 creator A5031925901 @default.
• W4286700957 creator A5056307286 @default.
• W4286700957 creator A5062338408 @default.
• W4286700957 creator A5063812427 @default.
• W4286700957 creator A5064649021 @default.
• W4286700957 creator A5088522170 @default.
• W4286700957 creator A5090403719 @default.
• W4286700957 date "2022-07-01" @default.
• W4286700957 modified "2023-09-27" @default.
• W4286700957 title "E-076 Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants (≤ 12 months): indications, technique, safety, and outcomes" @default.
• W4286700957 doi "https://doi.org/10.1136/neurintsurg-2022-snis.187" @default.
• W4286700957 hasPublicationYear "2022" @default.
• W4286700957 type Work @default.
• W4286700957 citedByCount "1" @default.
• W4286700957 countsByYear W42867009572023 @default.
• W4286700957 crossrefType "proceedings-article" @default.
• W4286700957 hasAuthorship W4286700957A5001897335 @default.
• W4286700957 hasAuthorship W4286700957A5006613712 @default.
• W4286700957 hasAuthorship W4286700957A5029305030 @default.
• W4286700957 hasAuthorship W4286700957A5031925901 @default.
• W4286700957 hasAuthorship W4286700957A5056307286 @default.
• W4286700957 hasAuthorship W4286700957A5062338408 @default.
• W4286700957 hasAuthorship W4286700957A5063812427 @default.
• W4286700957 hasAuthorship W4286700957A5064649021 @default.
• W4286700957 hasAuthorship W4286700957A5088522170 @default.
• W4286700957 hasAuthorship W4286700957A5090403719 @default.
• W4286700957 hasBestOaLocation W42867009571 @default.
• W4286700957 hasConcept C141071460 @default.
• W4286700957 hasConcept C2778230777 @default.
• W4286700957 hasConcept C2780813298 @default.
• W4286700957 hasConcept C2781156865 @default.
• W4286700957 hasConcept C71924100 @default.
• W4286700957 hasConceptScore W4286700957C141071460 @default.
• W4286700957 hasConceptScore W4286700957C2778230777 @default.
• W4286700957 hasConceptScore W4286700957C2780813298 @default.
• W4286700957 hasConceptScore W4286700957C2781156865 @default.
• W4286700957 hasConceptScore W4286700957C71924100 @default.
• W4286700957 hasLocation W42867009571 @default.
• W4286700957 hasOpenAccess W4286700957 @default.
• W4286700957 hasPrimaryLocation W42867009571 @default.
• W4286700957 hasRelatedWork W2030592900 @default.
• W4286700957 hasRelatedWork W2036527806 @default.
• W4286700957 hasRelatedWork W2069510170 @default.
• W4286700957 hasRelatedWork W2154362091 @default.
• W4286700957 hasRelatedWork W2363963413 @default.
• W4286700957 hasRelatedWork W2376445419 @default.
• W4286700957 hasRelatedWork W2896558888 @default.
• W4286700957 hasRelatedWork W2977919527 @default.
• W4286700957 hasRelatedWork W3032124713 @default.
• W4286700957 hasRelatedWork W3197353504 @default.
• W4286700957 isParatext "false" @default.
• W4286700957 isRetracted "false" @default.
• W4286700957 workType "article" @default.